Colon Cancer Liquid Biopsy Investigation of Methylation-based Biomarkers Evaluation Using Delta-HLD (CLIMBED)

Clinical trial NCT07168876 · RECRUITING

Trial details

NCT number: NCT07168876
Sponsor: Epiliquid Holding, Inc
Status: RECRUITING
Study type: OBSERVATIONAL

Colorectal Cancer (CRC)

Start date: 2024-04-04
Primary completion: 2025-12-01
Enrollment: 3200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.